Related Experiment Video
Updated: Jul 14, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Prevalence of antibodies to hepatitis C virus in hemodialysis patients in Riyadh
Y M Fakunle1, M Al-Mofarreh, W M El-Karamany
1Departments of Medicine, Nephrology, and Central Laboratory, Riyadh Central Hospital, Riyadh, Saudi Arabia.
Abstract:
Prevalence of antibodies to hepatitis C virus (anti-HCV) was determined in 190 adults (mean age 40.4 years; range 15 to 75) with end-stage renal disease (ESRD) who are on regular hemodialysis in the Nephrology Unit, Riyadh Central Hospital. The overall prevalence rate was 53.7% (48.7% and 61.0% in Saudi's and expatriates, respectively). These figures are considerably higher than figures of 34.8% reported from hemodialysis units in Riyadh, 20% in Spain, 5.5% in Germany, and 1% in the United Kingdom. The possible reasons for the high prevalence of this marker of HCV in our hemodialysis unit are considered and suggestions made for its control.
Related Concept Videos
Hepatitis
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Viral Hepatitis I: Introduction
